Disease profile and plasma neutralizing activity of post-vaccination Omicron BA.1 infection in Tianjin, China: a retrospective study

Affiliations

• ¹ Organ Transplant Center, NHC Key Laboratory for Critical Care Medicine, Tianjin First Central Hospital, Nankai University, Tianjin, China.
• ² Changping Laborarty, Beijing, China. [email protected].
• ³ Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, China. [email protected].
• ⁴ Frontier Research Center for Cell Response, Institute of Immunology, College of Life Sciences, Nankai University, Tianjin, China.
• ⁵ Institute of Hepatobiliary Disease, Tianjin Third Central Hospital, Tianjin, China.
• ⁶ Biomedical Pioneering Innovation Center (BIOPIC), Peking University, Beijing, China.
• ⁷ Department of Immunology, Center for Immunotherapy, Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences, Beijing, China.
• ⁸ Changping Laborarty, Beijing, China.
• ⁹ Beijing Youan Hospital, Capital Medical University, Beijing, China.
• ¹⁰ National Key Laboratory of Medical Immunology, Institute of Immunology, Navy Medical University, Shanghai, China.
• ¹¹ Organ Transplant Center, NHC Key Laboratory for Critical Care Medicine, Tianjin First Central Hospital, Nankai University, Tianjin, China. [email protected].